Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Only patients who meet all of the following eligibility criteria can be enrolled in this trial: 1. Patients aged >=18 years, male or female; 2. Lung cancer confirmed by histological or cytological pathology; 3. Patients diagnosed with brain metastasis or meningeal metastasis; 4. Patients underwent magnetic resonance cerebrospinal fluid film imaging assessment.
Exclusion criteria
Exclusion criteria: Patients with any of the following will not be included in this study: 1. Currently combined with other tumors except NSCLC; 2. Suffering from other malignant tumors or having a history of other malignant tumors in the past 5 years, except for basal cell carcinoma of the skin, cervical carcinoma in situ and breast ductal carcinoma in situ that have been effectively controlled;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The accuracy of MRI cerebrospinal fluid film in predicting lung cancer with early meningeal metastasis; | — |
Countries
China
Contacts
The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital